- NeuroBo Pharmaceuticals press release (NASDAQ:NRBO): FY GAAP EPS of -$2.46.
- Cash was $22.4 million as of December 31, 2023, compared with $33.4 million as of December 31, 2022.
NeuroBo Pharmaceuticals GAAP EPS of -$2.46
Recommended For You
More Trending News
About NRBO Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| NRBO | - | - |
| NeuroBo Pharmaceuticals, Inc. | ||